Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Prognostic Significance of Arterial Lactate Levels at Weaning from Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation

Biancari, Fausto ; Fiore, Antonio ; Jónsson, Kristján ; Gatti, Giuseppe ; Zipfel, Svante ; Ruggieri, Vito G ; Perrotti, Andrea ; Bounader, Karl ; Loforte, Antonio and Lechiancole, Andrea , et al. (2019) In Journal of Clinical Medicine 8(12).
Abstract

BACKGROUND: The outcome after weaning from postcardiotomy venoarterial extracorporeal membrane oxygenation (VA-ECMO) is poor. In this study, we investigated the prognostic impact of arterial lactate levels at the time of weaning from postcardiotomy VA.

METHODS: This analysis included 338 patients from the multicenter PC-ECMO registry with available data on arterial lactate levels at weaning from VA-ECMO.

RESULTS: Arterial lactate levels at weaning from VA-ECMO (adjusted OR 1.426, 95%CI 1.157-1.758) was an independent predictor of hospital mortality, and its best cutoff values was 1.6 mmol/L (<1.6 mmol/L, 26.2% vs. ≥ 1.6 mmol/L, 45.0%; adjusted OR 2.489, 95%CI 1.374-4.505). When 261 patients with arterial lactate at... (More)

BACKGROUND: The outcome after weaning from postcardiotomy venoarterial extracorporeal membrane oxygenation (VA-ECMO) is poor. In this study, we investigated the prognostic impact of arterial lactate levels at the time of weaning from postcardiotomy VA.

METHODS: This analysis included 338 patients from the multicenter PC-ECMO registry with available data on arterial lactate levels at weaning from VA-ECMO.

RESULTS: Arterial lactate levels at weaning from VA-ECMO (adjusted OR 1.426, 95%CI 1.157-1.758) was an independent predictor of hospital mortality, and its best cutoff values was 1.6 mmol/L (<1.6 mmol/L, 26.2% vs. ≥ 1.6 mmol/L, 45.0%; adjusted OR 2.489, 95%CI 1.374-4.505). When 261 patients with arterial lactate at VA-ECMO weaning ≤2.0 mmol/L were analyzed, a cutoff of arterial lactate of 1.4 mmol/L for prediction of hospital mortality was identified (<1.4 mmol/L, 24.2% vs. ≥1.4 mmol/L, 38.5%, p = 0.014). Among 87 propensity score-matched pairs, hospital mortality was significantly higher in patients with arterial lactate ≥1.4 mmol/L (39.1% vs. 23.0%, p = 0.029) compared to those with lower arterial lactate.

CONCLUSIONS: Increased arterial lactate levels at the time of weaning from postcardiotomy VA-ECMO increases significantly the risk of hospital mortality. Arterial lactate may be useful in guiding optimal timing of VA-ECMO weaning.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Clinical Medicine
volume
8
issue
12
article number
2218
publisher
MDPI AG
external identifiers
  • scopus:85096161118
  • pmid:31847464
ISSN
2077-0383
DOI
10.3390/jcm8122218
language
English
LU publication?
yes
id
7f4f08bf-d12c-479a-a6c1-e7f0f80f4a42
date added to LUP
2023-11-16 10:08:59
date last changed
2024-04-14 16:55:56
@article{7f4f08bf-d12c-479a-a6c1-e7f0f80f4a42,
  abstract     = {{<p>BACKGROUND: The outcome after weaning from postcardiotomy venoarterial extracorporeal membrane oxygenation (VA-ECMO) is poor. In this study, we investigated the prognostic impact of arterial lactate levels at the time of weaning from postcardiotomy VA.</p><p>METHODS: This analysis included 338 patients from the multicenter PC-ECMO registry with available data on arterial lactate levels at weaning from VA-ECMO.</p><p>RESULTS: Arterial lactate levels at weaning from VA-ECMO (adjusted OR 1.426, 95%CI 1.157-1.758) was an independent predictor of hospital mortality, and its best cutoff values was 1.6 mmol/L (&lt;1.6 mmol/L, 26.2% vs. ≥ 1.6 mmol/L, 45.0%; adjusted OR 2.489, 95%CI 1.374-4.505). When 261 patients with arterial lactate at VA-ECMO weaning ≤2.0 mmol/L were analyzed, a cutoff of arterial lactate of 1.4 mmol/L for prediction of hospital mortality was identified (&lt;1.4 mmol/L, 24.2% vs. ≥1.4 mmol/L, 38.5%, p = 0.014). Among 87 propensity score-matched pairs, hospital mortality was significantly higher in patients with arterial lactate ≥1.4 mmol/L (39.1% vs. 23.0%, p = 0.029) compared to those with lower arterial lactate.</p><p>CONCLUSIONS: Increased arterial lactate levels at the time of weaning from postcardiotomy VA-ECMO increases significantly the risk of hospital mortality. Arterial lactate may be useful in guiding optimal timing of VA-ECMO weaning.</p>}},
  author       = {{Biancari, Fausto and Fiore, Antonio and Jónsson, Kristján and Gatti, Giuseppe and Zipfel, Svante and Ruggieri, Vito G and Perrotti, Andrea and Bounader, Karl and Loforte, Antonio and Lechiancole, Andrea and Saeed, Diyar and Lichtenberg, Artur and Pol, Marek and Spadaccio, Cristiano and Pettinari, Matteo and Mogianos, Krister and Alkhamees, Khalid and Mariscalco, Giovanni and El Dean, Zein and Settembre, Nicla and Welp, Henryk and Dell'Aquila, Angelo M and Fux, Thomas and Juvonen, Tatu and Dalén, Magnus}},
  issn         = {{2077-0383}},
  language     = {{eng}},
  month        = {{12}},
  number       = {{12}},
  publisher    = {{MDPI AG}},
  series       = {{Journal of Clinical Medicine}},
  title        = {{Prognostic Significance of Arterial Lactate Levels at Weaning from Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation}},
  url          = {{http://dx.doi.org/10.3390/jcm8122218}},
  doi          = {{10.3390/jcm8122218}},
  volume       = {{8}},
  year         = {{2019}},
}